Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

CUSIP: 23954D109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101,960,784
Total 13F shares
77,547,732
Share change
-1,844,515
Total reported value
$951,517,363
Put/Call ratio
214%
Price per share
$12.27
Number of holders
127
Value change
-$22,223,998
Number of buys
67
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 23954D109?
CUSIP 23954D109 identifies DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q3 2023

As of 30 Sep 2023, Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 77,547,732 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BRAIDWELL LP, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, and Canaan Partners XI LLC. This page lists 127 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.